Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1922 1
1953 1
1959 1
1960 1
1961 3
1964 3
1965 1
1966 3
1967 4
1968 4
1969 3
1970 3
1971 1
1973 2
1974 3
1975 2
1976 3
1977 4
1978 1
1979 2
1980 1
1982 1
1983 1
1984 1
1986 1
1987 1
1988 3
1989 3
1990 3
1991 2
1992 7
1993 4
1994 5
1995 6
1996 6
1997 5
1998 13
1999 6
2000 14
2001 10
2002 15
2003 10
2004 18
2005 17
2006 34
2007 42
2008 38
2009 44
2010 42
2011 48
2012 77
2013 80
2014 91
2015 99
2016 104
2017 87
2018 102
2019 127
2020 100
Text availability
Article attribute
Article type
Publication date

Search Results

1,175 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Brazinskas
Page 1
Paradigm shift: the Copernican revolution in diverticular disease.
Zullo A, Gatta L, Vassallo R, Francesco V, Manta R, Monica F, Fiorini G, Vaira D. Zullo A, et al. Ann Gastroenterol. 2019 Nov-Dec;32(6):541-553. doi: 10.20524/aog.2019.0410. Epub 2019 Aug 2. Ann Gastroenterol. 2019. PMID: 31700230 Free PMC article. Review.
The etiopathogenesis of uterine fibromatosis.
Manta L, Suciu N, Toader O, Purcărea RM, Constantin A, Popa F. Manta L, et al. J Med Life. 2016 Jan-Mar;9(1):39-45. J Med Life. 2016. PMID: 27974911 Free PMC article. Review.
Greece.
Zikos D, Diomidous M, Mantas J, Kaitelidou D, Karanikolos M. Zikos D, et al. In: Rafferty AM, Busse R, Zander-Jentsch B, Sermeus W, Bruyneel L, editors. Strengthening health systems through nursing: Evidence from 14 European countries [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2019. 5. Strengthening health systems through nursing: Evidence from 14 European countries. 2019. PMID: 31465167 Free Books & Documents. Review. No abstract available.
Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.
Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Källberg M, Cox AJ, Kruglyak S, Saunders CT. Chen X, et al. Bioinformatics. 2016 Apr 15;32(8):1220-2. doi: 10.1093/bioinformatics/btv710. Epub 2015 Dec 8. Bioinformatics. 2016. PMID: 26647377
We provide Manta as a community resource to facilitate practical and routine structural variant analysis in clinical and research sequencing scenarios. AVAILABILITY AND IMPLEMENTATION: Manta is released under the open-source GPLv3 license. Source code, documentation …
We provide Manta as a community resource to facilitate practical and routine structural variant analysis in clinical and research seq …
MANTA Dedicated Large-Bore Vessel Closure Device.
Tarantini G. Tarantini G. Circ Cardiovasc Interv. 2019 Jul;12(7):e008203. doi: 10.1161/CIRCINTERVENTIONS.119.008203. Epub 2019 Jul 12. Circ Cardiovasc Interv. 2019. PMID: 31296083 No abstract available.
Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.
Wood DA, Krajcer Z, Sathananthan J, Strickman N, Metzger C, Fearon W, Aziz M, Satler LF, Waksman R, Eng M, Kapadia S, Greenbaum A, Szerlip M, Heimansohn D, Sampson A, Coady P, Rodriguez R, Krishnaswamy A, Lee JT, Ben-Dor I, Moainie S, Kodali S, Chhatriwalla AK, Yadav P, O'Neill B, Kozak M, Bacharach JM, Feldman T, Guerrero M, Nanjundappa A, Bersin R, Zhang M, Potluri S, Barker C, Bernardo N, Lumsden A, Barleben A, Campbell J, Cohen DJ, Dake M, Brown D, Maor N, Nardone S, Lauck S, O'Neill WW, Webb JG; SAFE MANTA Study Investigators. Wood DA, et al. Circ Cardiovasc Interv. 2019 Jul;12(7):e007258. doi: 10.1161/CIRCINTERVENTIONS.119.007258. Epub 2019 Jul 12. Circ Cardiovasc Interv. 2019. PMID: 31296082 Clinical Trial.
The MANTA vascular closure device is a novel collagen-based technology designed to close large bore arteriotomies created by devices with an outer diameter ranging from 12F to 25F. ...The 14F MANTA was used in 42 cases (16%), and the 18F was used in 221 cases(84%). …
The MANTA vascular closure device is a novel collagen-based technology designed to close large bore arteriotomies created by devices …
Social and Psychological Effects of the Internet Use.
Diomidous M, Chardalias K, Magita A, Koutonias P, Panagiotopoulou P, Mantas J. Diomidous M, et al. Acta Inform Med. 2016 Feb;24(1):66-8. doi: 10.5455/aim.2016.24.66-68. Epub 2016 Feb 2. Acta Inform Med. 2016. PMID: 27041814 Free PMC article. Review.
Insights From a Multidisciplinary Introduction of the MANTA Vascular Closure Device.
Moccetti F, Brinkert M, Seelos R, Ockert S, Bossard M, Cuculi F, Kobza R, Toggweiler S. Moccetti F, et al. JACC Cardiovasc Interv. 2019 Sep 9;12(17):1730-1736. doi: 10.1016/j.jcin.2019.06.049. JACC Cardiovasc Interv. 2019. PMID: 31488301
OBJECTIVES: The aim of this paper is to report insights from the first 100 consecutive cardiovascular procedures with MANTA closure. ...In these 100 patients, a total of 122 MANTA devices were used (22 patients had bilateral large-bore access). None of the patients …
OBJECTIVES: The aim of this paper is to report insights from the first 100 consecutive cardiovascular procedures with MANTA closure. …
MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.
Biancari F, Romppanen H, Savontaus M, Siljander A, Mäkikallio T, Piira OP, Piuhola J, Vilkki V, Ylitalo A, Vasankari T, Airaksinen JKE, Niemelä M. Biancari F, et al. Int J Cardiol. 2018 Jul 15;263:29-31. doi: 10.1016/j.ijcard.2018.04.065. Epub 2018 Apr 14. Int J Cardiol. 2018. PMID: 29681408 Clinical Trial.
The MANTA VCD was used in 107 patients and their outcome was compared with that of 115 patients in whom the arterial access was closed with the ProGlide VCD. RESULTS: VARC-2 VCD failure occurred less frequently in the MANTA cohort (3.7% vs. 7.8%, p = 0.378), but the …
The MANTA VCD was used in 107 patients and their outcome was compared with that of 115 patients in whom the arterial access was close …
Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide.
Hoffmann P, Al-Ani A, von Lueder T, Hoffmann J, Majak P, Hagen O, Loose H, Kløw NE, Opdahl A. Hoffmann P, et al. CVIR Endovasc. 2018;1(1):20. doi: 10.1186/s42155-018-0026-0. Epub 2018 Sep 21. CVIR Endovasc. 2018. PMID: 30652151 Free PMC article.
Complications occurred in 2 (2.7%) ProGlide and in 8 (10.7%) Manta cases, p = 0.047. During the learning phase there were no significant differences. In the established phase there was one event (2%) in the ProGlide group, compared to 6 endpoints (12.0%), p = 0.047, in the …
Complications occurred in 2 (2.7%) ProGlide and in 8 (10.7%) Manta cases, p = 0.047. During the learning phase there were no signific …
1,175 results
Jump to page
Feedback